Plus   Neg

Zimmer Biomet Reinitiates FY21 Outlook - Quick Facts

While reporting financial results for the first quarter on Tuesday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) re-initiated its adjusted earnings and revenue growth outlook for the full-year 2021.

For fiscal 2021, the company now expects adjusted earnings in a range of $7.60 to $8.00 per share on projected revenue growth of 14 to 17 percent from last year on a reported basis.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.72 per share on revenue growth of 13.5 percent to $7.97 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT